12/14
01:26 am
inmb
Medium
Report
12/5
07:00 am
inmb
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
Low
Report
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
12/1
08:52 am
inmb
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595's Evidence Base in High-Inflammation Alzheimer's Patients [Yahoo! Finance]
High
Report
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595's Evidence Base in High-Inflammation Alzheimer's Patients [Yahoo! Finance]
12/1
08:00 am
inmb
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
High
Report
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
11/18
08:00 am
inmb
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
Low
Report
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
11/9
01:13 am
inmb
Medium
Report
10/30
04:12 pm
inmb
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update [Yahoo! Finance]
Low
Report
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update [Yahoo! Finance]
10/30
04:05 pm
inmb
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
Medium
Report
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
10/23
07:00 am
inmb
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
Neutral
Report
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025